E-LIB Suche - Ergebnisse für: van Haarst, Aernout D.

1

Randomized trial of pharmacokinetic and pharmacodynamic eff..:

Dworaczyk, David A. ; Hunt, Allen ; Di Spirito, Mike...
Annals of Allergy, Asthma & Immunology. 133 (2024) 2 - p. 186-193.e2 , 2024

Link: https://doi.org/10.1016/..

2

Should You Run a Dedicated TQT Study? Sponsor and Regulator..:

Lester, Robert M. ; Engel, Caroline ; van Haarst, Aernout D..
Clinical Pharmacology & Therapeutics. 116 (2024) 1 - p. 42-51 , 2024

Link: https://doi.org/10.1002/..

3

Innovative Approaches to Optimize Clinical Transporter Drug..:

Paglialunga, Sabina ; Benrimoh, Natacha ; van Haarst, Aernout
Pharmaceutics. 16 (2024) 8 - p. 992 , 2024

Link: https://doi.org/10.3390/..

4

The Impact of N-nitrosamine Impurities on Clinical Drug Dev..:

Paglialunga, Sabina ; van Haarst, Aernout
Journal of Pharmaceutical Sciences. 112 (2023) 5 - p. 1183-1191 , 2023

Link: https://doi.org/10.1016/..

5

Rifampin Drug–Drug–Interaction Studies: Reflections on the ..:

van Haarst, Aernout ; Smith, Stephen ; Garvin, Clare..
Clinical Pharmacology & Therapeutics. 113 (2022) 4 - p. 816-821 , 2022

Link: https://doi.org/10.1002/..

6

Review of Drug Development Guidance to Treat Chronic Obstru..:

van Haarst, Aernout ; McGarvey, Lorcan ; Paglialunga, Sabina
Clinical Pharmacology & Therapeutics. 106 (2019) 6 - p. 1222-1235 , 2019

Link: https://doi.org/10.1002/..

7

Clinically Important Interaction Between Tedisamil and Vera..:

van Haarst, Aernout D. ; Dijkmans, Anneke C. ; Weimann, Hans‐Josef...
The Journal of Clinical Pharmacology. 49 (2009) 5 - p. 560-567 , 2009

Link: https://doi.org/10.1177/..

8

Effects of a nonpeptide motilin receptor antagonist on prox..:

Kamerling, Ingrid M. C. ; Van Haarst, Aernout D. ; Burggraaf, Jacobus...
British Journal of Clinical Pharmacology. 57 (2004) 4 - p. 393-401 , 2004

Link: https://doi.org/10.1046/..

9

The influence of cisapride and clarithromycin on QT interva..:

van Haarst, Aernout D. ; van't Klooster, Gerben A. E. ; van Gerven, Joop M. A....
Clinical Pharmacology & Therapeutics. 64 (1998) 5 - p. 542-546 , 1998

Link: https://doi.org/10.1016/..

10

Corticosterone, brain mineralocorticoid receptors (MRS) and..:

Oitzl, Melly S. ; van Haarst, Aernout D. ; Sutanto, Win.
Psychoneuroendocrinology. 20 (1995) 6 - p. 655-675 , 1995

Link: https://doi.org/10.1016/..

11

Brain mineralocorticoid receptor diversity: Functional impl..:

Ronald de Kloet, E. ; Sutanto, Win ; van den Berg, Désirée T.W.M....
The Journal of Steroid Biochemistry and Molecular Biology. 47 (1993) 1-6 - p. 183-190 , 1993

Link: https://doi.org/10.1016/..

12

Review of Drug Development Guidance to Treat Chronic Obstru..:

van Haarst, Aernout ; McGarvey, Lorcan ; Paglialunga, Sabina
van Haarst , A , McGarvey , L & Paglialunga , S 2019 , ' Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives ' , Clinical Pharmacology and Therapeutics , vol. 106 , no. 6 , pp. 1222-1235 . https://doi.org/10.1002/cpt.1540. , 2019

Link: https://pure.qub.ac.uk/e..

13

Review of Drug Development Guidance to Treat Chronic Obstru..:

van Haarst, Aernout ; McGarvey, Lorcan ; Paglialunga, Sabina
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896238/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Effects of a nonpeptide motilin receptor antagonist on prox..:

Kamerling, Ingrid M C ; van Haarst, Aernout D ; Burggraaf, Jacobus...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884467. , 2004

Link: http://www.ncbi.nlm.nih...